An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.

The influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 inf...

Full description

Bibliographic Details
Main Authors: Runming Li, Deshou Song, Zhibo Zhu, Hanhong Xu, Shuwen Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3410875?pdf=render
_version_ 1798045486680113152
author Runming Li
Deshou Song
Zhibo Zhu
Hanhong Xu
Shuwen Liu
author_facet Runming Li
Deshou Song
Zhibo Zhu
Hanhong Xu
Shuwen Liu
author_sort Runming Li
collection DOAJ
description The influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 influenza virus, CL-385319, which specifically inhibits HA-mediated viral entry. Studies presented here identified the critical binding residues for CL-385319, which clustered in the stem region of the HA trimer by site-directed mutagenesis. Extensive computational simulations, including molecular docking, molecular dynamics simulations, molecular mechanics generalized Born surface area (MM_GBSA) calculations, charge density and Laplacian calculations, have been carried out to uncover the detailed molecular mechanism that underlies the binding of CL-385319 to H5N1 influenza virus HA. It was found that the recognition and binding of CL-385319 to HA proceeds by a process of "induced fit" whereby the binding pocket is formed during their interaction. Occupation of this pocket by CL-385319 stabilizes the neutral pH structure of hemagglutinin, thus inhibiting the conformational rearrangements required for membrane fusion. This "induced fit" pocket may be a target for structure-based design of more potent influenza fusion inhibitors.
first_indexed 2024-04-11T23:22:46Z
format Article
id doaj.art-02d053b24edc4604ad876be0481f3a01
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T23:22:46Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-02d053b24edc4604ad876be0481f3a012022-12-22T03:57:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4195610.1371/journal.pone.0041956An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.Runming LiDeshou SongZhibo ZhuHanhong XuShuwen LiuThe influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 influenza virus, CL-385319, which specifically inhibits HA-mediated viral entry. Studies presented here identified the critical binding residues for CL-385319, which clustered in the stem region of the HA trimer by site-directed mutagenesis. Extensive computational simulations, including molecular docking, molecular dynamics simulations, molecular mechanics generalized Born surface area (MM_GBSA) calculations, charge density and Laplacian calculations, have been carried out to uncover the detailed molecular mechanism that underlies the binding of CL-385319 to H5N1 influenza virus HA. It was found that the recognition and binding of CL-385319 to HA proceeds by a process of "induced fit" whereby the binding pocket is formed during their interaction. Occupation of this pocket by CL-385319 stabilizes the neutral pH structure of hemagglutinin, thus inhibiting the conformational rearrangements required for membrane fusion. This "induced fit" pocket may be a target for structure-based design of more potent influenza fusion inhibitors.http://europepmc.org/articles/PMC3410875?pdf=render
spellingShingle Runming Li
Deshou Song
Zhibo Zhu
Hanhong Xu
Shuwen Liu
An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
PLoS ONE
title An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
title_full An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
title_fullStr An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
title_full_unstemmed An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
title_short An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
title_sort induced pocket for the binding of potent fusion inhibitor cl 385319 with h5n1 influenza virus hemagglutinin
url http://europepmc.org/articles/PMC3410875?pdf=render
work_keys_str_mv AT runmingli aninducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT deshousong aninducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT zhibozhu aninducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT hanhongxu aninducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT shuwenliu aninducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT runmingli inducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT deshousong inducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT zhibozhu inducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT hanhongxu inducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin
AT shuwenliu inducedpocketforthebindingofpotentfusioninhibitorcl385319withh5n1influenzavirushemagglutinin